- Home
- EVGN vs APM Comparison
EVGN vs APM Comparison
Compare EVGN & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVGN | APM |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 10.7M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | EVGN | APM |
|---|---|---|
| Price | $1.07 | $1.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | 47.7K | ★ 104.9K |
| Earning Date | 11-20-2025 | 12-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,016,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.35 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.19 | N/A |
| 52 Week Low | $0.95 | $0.67 |
| 52 Week High | $2.42 | $7.49 |
Technical Indicators
Market Signals| Indicator | EVGN | APM |
|---|---|---|
| Relative Strength Index (RSI) | 39.20 | 39.60 |
| Support Level | $1.07 | $1.30 |
| Resistance Level | $1.12 | $1.38 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 21.05 | 15.95 |
Price Performance
Historical ComparisonAbout EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.